Mesoblast Limited Securities Litigation

According to the Complaint, Mesoblast Limited develops allogeneic cellular medicines using its proprietary mesenchymal lineage cell therapy platform. Its lead product candidate, RYONCIL (remestemcelL), is an investigational therapy comprising mesenchymal stem cells derived from bone marrow.

See Case Details »

Royal Caribbean Cruises LTD Securities Litigation (2020)

According to the Complaint, Royal Caribbean Cruises LTD is currently the second largest cruise line company in the world behind Carnival.

See Case Details »

Precigen, Inc. Securities Litigation

According to the Complaint, Precigen, Inc. (formerly known as Intrexon Corporation) purportedly operates in the synthetic biology field and creates biologically-based products. During the Class Period, the Company's securities traded on the New York Stock Exchange under the ticker symbol "XON" until September 25, 2018, when the Company's stock began trading on the NASDAQ market. On February 1, 2020, the Company changed its name to "Precigen, Inc." and its stock symbol to "PGEN."

See Case Details »

Credit Acceptance Corporation Securities Litigation (2020)

According to the Complaint, Credit Acceptance Corporation is a subprime auto finance company providing loans and other related financial products that enable automobile dealers to sell vehicles to consumers. In 2019, Credit Acceptance funded about 370,000 subprime auto loans nation-wide of which over 95% were subprime loans. A substantial portion of Credit Acceptance's loans are never repaid. The Company also securitizes and sells its loans to investors.

See Case Details »

Aurora Cannabis Inc. Securities Litigation (2020)

According to the Complaint, Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide.

See Case Details »